Silo Pharma (SILO) Competitors $0.65 -0.03 (-3.78%) Closing price 03:59 PM EasternExtended Trading$0.66 +0.01 (+1.60%) As of 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SILO vs. PMNT, EVKG, ONON, LULU, AS, BIRK, LEVI, GIL, KTB, and BRPShould you be buying Silo Pharma stock or one of its competitors? The main competitors of Silo Pharma include Perfect Moment (PMNT), Ever-Glory International Group (EVKG), ON (ONON), lululemon athletica (LULU), Amer Sports (AS), Birkenstock (BIRK), Levi Strauss & Co. (LEVI), Gildan Activewear (GIL), Kontoor Brands (KTB), and The Baldwin Insurance Group (BRP). These companies are all part of the "apparel" industry. Silo Pharma vs. Its Competitors Perfect Moment Ever-Glory International Group ON lululemon athletica Amer Sports Birkenstock Levi Strauss & Co. Gildan Activewear Kontoor Brands The Baldwin Insurance Group Perfect Moment (NASDAQ:PMNT) and Silo Pharma (NASDAQ:SILO) are both small-cap apparel companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment. Which has stronger earnings & valuation, PMNT or SILO? Silo Pharma has lower revenue, but higher earnings than Perfect Moment. Silo Pharma is trading at a lower price-to-earnings ratio than Perfect Moment, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPerfect Moment$22.00M0.67-$8.72M-$0.98-0.48Silo Pharma$70K88.45-$4.39M-$1.05-0.62 Does the media favor PMNT or SILO? In the previous week, Silo Pharma had 5 more articles in the media than Perfect Moment. MarketBeat recorded 6 mentions for Silo Pharma and 1 mentions for Perfect Moment. Perfect Moment's average media sentiment score of 1.00 beat Silo Pharma's score of 0.44 indicating that Perfect Moment is being referred to more favorably in the media. Company Overall Sentiment Perfect Moment Positive Silo Pharma Neutral Is PMNT or SILO more profitable? Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -6,798.61%. Silo Pharma's return on equity of -94.39% beat Perfect Moment's return on equity.Company Net Margins Return on Equity Return on Assets Perfect Moment-67.38% -513.83% -119.38% Silo Pharma -6,798.61%-94.39%-68.62% Do institutionals and insiders have more ownership in PMNT or SILO? 23.0% of Perfect Moment shares are held by institutional investors. Comparatively, 5.6% of Silo Pharma shares are held by institutional investors. 4.4% of Silo Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, PMNT or SILO? Perfect Moment has a beta of -3.47, indicating that its share price is 447% less volatile than the S&P 500. Comparatively, Silo Pharma has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. SummarySilo Pharma beats Perfect Moment on 7 of the 13 factors compared between the two stocks. Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SILO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SILO vs. The Competition Export to ExcelMetricSilo PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.19M$3.13B$5.79B$10.15BDividend YieldN/A2.32%5.69%4.60%P/E Ratio-0.6221.3074.5925.92Price / Sales88.45257.21453.5485.33Price / CashN/A45.3337.0859.91Price / Book0.589.6112.156.29Net Income-$4.39M-$53.29M$3.28B$270.77M7 Day Performance7.21%0.28%0.99%3.36%1 Month Performance-2.89%8.91%7.21%6.41%1 Year Performance-39.40%13.14%63.07%28.24% Silo Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SILOSilo Pharma0.6214 of 5 stars$0.65-3.8%N/A-41.9%$6.19M$70K-0.622Positive NewsGap DownPMNTPerfect Moment1.0217 of 5 stars$0.45-7.2%N/A-50.6%$14.02M$22.00M-0.3431Positive NewsShort Interest ↓Gap DownEVKGEver-Glory International GroupN/A$0.00flatN/AN/A$10KN/A0.004,300ONONON4.1743 of 5 stars$44.82-0.6%$64.20+43.2%-6.9%$28.38B$2.63B99.613,254Positive NewsLULUlululemon athletica4.6928 of 5 stars$200.21-1.0%$303.83+51.8%-35.0%$24.23B$10.59B13.5639,000Trending NewsAnalyst DowngradeOptions VolumeAnalyst RevisionASAmer Sports3.3974 of 5 stars$37.98-3.4%$41.62+9.6%+165.9%$21.78B$5.18B92.6413,400Positive NewsBIRKBirkenstock3.3807 of 5 stars$50.42-3.3%$68.58+36.0%+6.0%$9.79B$1.96B28.017,400Trending NewsAnalyst RevisionLEVILevi Strauss & Co.3.7348 of 5 stars$22.65+1.3%$23.45+3.5%+14.4%$8.85B$6.36B22.2118,700GILGildan Activewear4.7156 of 5 stars$52.46-3.9%$64.58+23.1%+22.9%$8.15B$3.27B16.6550,000Positive NewsShort Interest ↑KTBKontoor Brands4.4079 of 5 stars$79.40+2.8%$89.67+12.9%+16.7%$4.29B$2.61B17.7213,200News CoveragePositive NewsEx-DividendAnalyst ForecastBRPThe Baldwin Insurance GroupN/A$31.67+0.2%N/A-33.7%$3.72B$1.27B-34.429,200 Related Companies and Tools Related Companies Perfect Moment Competitors Ever-Glory International Group Competitors ON Competitors lululemon athletica Competitors Amer Sports Competitors Birkenstock Competitors Levi Strauss & Co. Competitors Gildan Activewear Competitors Kontoor Brands Competitors The Baldwin Insurance Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SILO) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.